CXCL10 release in cardiopulmonary bypass: An in vivo and in vitro study-Reference-Cited by-同舟云学术

CXCL10 release in cardiopulmonary bypass: An in vivo and in vitro study

Published:2012-10 Issue:4 Volume:2 Page:187-194
ISSN:2210-5220
Container-title:Biomedicine & Aging Pathology
language:en
Short-container-title:Biomedicine & Aging Pathology

Author:

Scolletta Sabino,Buonamano Andrea,Sottili Mariangela,Giomarelli Pierpaolo,Biagioli Bonizella,Vannelli Gabriella Barbara,Serio Mario,Romagnani Paola,Crescioli Clara

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Ageing,Pathology and Forensic Medicine

Reference43 articles.

1. Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean arterial pressure;Gold;J Thorac Cardiovasc Surg,1995

2. Preoperative atorvastatin therapy to decrease the systemic inflammatory response after coronary artery bypass grafting;Dereli;J Int Med Res,2008

3. Simvastatin suppresses lung inflammatory response in a rat cardiopulmonary bypass model;Shao;Ann Thorac Surg,2007

4. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine;McILwain;Lab Invest,2010

5. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure;Casey;Ann Thorac Surg,1993

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exercise-induced modulation of Interferon-signature: a therapeutic route toward management of Systemic Lupus Erythematosus;Autoimmunity Reviews;2023-10

2. The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis;International Journal of Molecular Sciences;2022-09-05

3. Cell-Target-Specific Anti-Inflammatory Effect of Empagliflozin: In Vitro Evidence in Human Cardiomyocytes;Frontiers in Molecular Biosciences;2022-05-31

4. Human cell-based anti-inflammatory effects of rosiglitazone;Journal of Endocrinological Investigation;2021-06-25

5. Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition;International Journal of Molecular Sciences;2021-03-12